ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,246,000 | +2.0% | 49,161 | +2.2% | 0.00% | – |
Q1 2024 | $1,222,000 | +3.3% | 48,112 | -7.8% | 0.00% | – |
Q4 2023 | $1,183,000 | +27.5% | 52,198 | +4.8% | 0.00% | – |
Q3 2023 | $928,000 | -29.6% | 49,792 | -1.7% | 0.00% | – |
Q2 2023 | $1,318,000 | +1.6% | 50,669 | +12.1% | 0.00% | – |
Q1 2023 | $1,297,000 | +50.6% | 45,187 | +55.5% | 0.00% | – |
Q4 2022 | $861,000 | -9.1% | 29,065 | -27.0% | 0.00% | – |
Q3 2022 | $947,000 | +4.4% | 39,814 | -2.0% | 0.00% | – |
Q2 2022 | $907,000 | -7.8% | 40,612 | +3.5% | 0.00% | – |
Q1 2022 | $984,000 | -35.8% | 39,235 | -8.2% | 0.00% | – |
Q4 2021 | $1,532,000 | -15.2% | 42,755 | +0.7% | 0.00% | – |
Q3 2021 | $1,806,000 | +1.0% | 42,451 | +2.7% | 0.00% | – |
Q2 2021 | $1,789,000 | +7.5% | 41,336 | +1.4% | 0.00% | – |
Q1 2021 | $1,664,000 | -28.6% | 40,774 | -20.8% | 0.00% | -100.0% |
Q4 2020 | $2,331,000 | +30.8% | 51,508 | +2.3% | 0.00% | 0.0% |
Q3 2020 | $1,782,000 | -5.4% | 50,367 | +0.9% | 0.00% | 0.0% |
Q2 2020 | $1,883,000 | +34.5% | 49,920 | +3.0% | 0.00% | 0.0% |
Q1 2020 | $1,400,000 | -41.3% | 48,460 | +5.4% | 0.00% | 0.0% |
Q4 2019 | $2,384,000 | -10.5% | 45,977 | -5.3% | 0.00% | 0.0% |
Q3 2019 | $2,665,000 | -14.4% | 48,554 | -36.7% | 0.00% | 0.0% |
Q2 2019 | $3,113,000 | +102.5% | 76,646 | +50.8% | 0.00% | 0.0% |
Q1 2019 | $1,537,000 | +7.3% | 50,819 | +19.3% | 0.00% | 0.0% |
Q4 2018 | $1,433,000 | -24.1% | 42,611 | -4.8% | 0.00% | 0.0% |
Q3 2018 | $1,887,000 | +41.8% | 44,744 | +7.6% | 0.00% | 0.0% |
Q2 2018 | $1,331,000 | -45.1% | 41,601 | -14.7% | 0.00% | 0.0% |
Q1 2018 | $2,425,000 | -3.7% | 48,756 | +4.3% | 0.00% | 0.0% |
Q4 2017 | $2,518,000 | -8.4% | 46,726 | -1.4% | 0.00% | 0.0% |
Q3 2017 | $2,750,000 | +39.5% | 47,412 | +18.7% | 0.00% | 0.0% |
Q2 2017 | $1,971,000 | +12.2% | 39,950 | -1.2% | 0.00% | 0.0% |
Q1 2017 | $1,757,000 | -4.9% | 40,421 | +7.0% | 0.00% | 0.0% |
Q4 2016 | $1,848,000 | +4.4% | 37,763 | +2.1% | 0.00% | 0.0% |
Q3 2016 | $1,770,000 | -14.0% | 36,987 | -3.5% | 0.00% | 0.0% |
Q2 2016 | $2,057,000 | +76.1% | 38,330 | +46.8% | 0.00% | 0.0% |
Q1 2016 | $1,168,000 | -19.1% | 26,106 | -31.0% | 0.00% | 0.0% |
Q4 2015 | $1,443,000 | +20.7% | 37,810 | +0.5% | 0.00% | 0.0% |
Q3 2015 | $1,196,000 | -2.9% | 37,612 | +0.8% | 0.00% | 0.0% |
Q2 2015 | $1,232,000 | +10.3% | 37,302 | +37.5% | 0.00% | 0.0% |
Q1 2015 | $1,117,000 | +5.0% | 27,131 | +3.8% | 0.00% | 0.0% |
Q4 2014 | $1,064,000 | +71.9% | 26,131 | +54.9% | 0.00% | – |
Q3 2014 | $619,000 | -19.7% | 16,875 | +1.4% | 0.00% | -100.0% |
Q2 2014 | $771,000 | +11.6% | 16,650 | -0.9% | 0.00% | 0.0% |
Q1 2014 | $691,000 | +10.4% | 16,800 | +2.4% | 0.00% | – |
Q4 2013 | $626,000 | +63.4% | 16,400 | +2.6% | 0.00% | – |
Q3 2013 | $383,000 | +32.5% | 15,987 | -6.0% | 0.00% | – |
Q2 2013 | $289,000 | – | 17,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |